[outofsalt]

I was an early investor in DNDN and didn’t sell on their first FDA ad. comm. rode it up and back down when the FDA asked for more data. That was a gut punch.

I held for two years and made a killing on approval. By that point I had learned to take profits. I hope they find a buyer to keep Provenge available. Immunotherapy will be huge someday.

[struwwelpeter]

Some guys in my support group rave about it, but after some research I found that Provenge / Sipuleucel-T doesn't stop progression of the disease or improve quality of life, and costs $93,000 for each treatment.

For a life expectancy on average 4 months longer than placebo.

[cicero2k]

As an 11 year survivor, I was thinking Provenge would be on my horizon. Perhaps not. It looked like it had substantially more than 4 months benefit if it was started before initial PSA was too high.

Praying for continuing remission.

[Graybeard58]

Several years back, I invested $250 in a British pharmaceutical co. Over the next 5 years and several bassackward splits, my stock was worth less than $10. I told them to close my account. They wrote back and said there was a $10 fee for that. I ignored it but they closed my account anyway.

Yep, I lost a few quid. (Whatever a quid is.

[Tired of Taxes]

CANCER WARRIORS PING

This is a ping list for cancer survivors and caregivers to share information. If you would like your name added to or removed from this ping list, please tell us in the comments section at this link (click here). (For the most updated list of names, click on the same link and go to the last comment.)